expert roundtables

Oncology

Treatment of Relapsed Mantle Cell Lymphoma Following Extended Response to Prior Therapy

expert roundtables
By Brad Kahl, MD; Julie M. Vose, MD, MBA, FASCO; Thomas J. Kipps, MD, PhD
Recommendations for Appropriate Use of Autologous Stem Cell Transplantation in a First-line Regimen for Mantle Cell Lymphoma
Oncology

Recommendations for Appropriate Use of Autologous Stem Cell Transplantation in a First-line Regimen for Mantle Cell Lymphoma

expert roundtables
By Brad Kahl, MD; Julie M. Vose, MD, MBA, FASCO; Thomas J. Kipps, MD, PhD
Myeloproliferative Neoplasms: Risk Stratification and Response Evaluation
Oncology

Myeloproliferative Neoplasms: Risk Stratification and Response Evaluation

expert roundtables
By Katherine Walsh, MD, FACP; Rami S. Komrokji, MD; Ruben A. Mesa, MD, FACP
Polycythemia Vera: Factors That May Warrant a Change in Cytoreductive Therapy
Oncology

Polycythemia Vera: Factors That May Warrant a Change in Cytoreductive Therapy

expert roundtables
By Katherine Walsh, MD, FACP; Rami S. Komrokji, MD; Ruben A. Mesa, MD, FACP
Most Effective Outcome Measures for Assessing Treatment Response in Relapsed/Refractory Chronic Lymphocytic Leukemia
Oncology

Most Effective Outcome Measures for Assessing Treatment Response in Relapsed/Refractory Chronic Lymphocytic Leukemia

expert roundtables
By Bruce D. Cheson, MD, FACP, FAAAS, FASCO; Jennifer R. Brown, MD, PhD
Load More